e-learning
resources
Stockholm 2007
Wednesday 19.09.2007
Pleural malignancy
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Timp-2 expression in the cytologic evaluation of adenocarcinoma pleural effusions
E. Giarnieri, S. Mariotta, G. De Francesco, A. Ricci, D. Silvestri, M. R. Giovagnoli (Rome, Italy)
Source:
Annual Congress 2007 - Pleural malignancy
Session:
Pleural malignancy
Session type:
Oral Presentation
Number:
4453
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Giarnieri, S. Mariotta, G. De Francesco, A. Ricci, D. Silvestri, M. R. Giovagnoli (Rome, Italy). Timp-2 expression in the cytologic evaluation of adenocarcinoma pleural effusions. Eur Respir J 2007; 30: Suppl. 51, 4453
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Management of solitary fibrous tumours of the pleura: a systematic review and meta-analysis
Utility of pleural fluid for predictive marker testing in malignant pleural effusion
Related content which might interest you:
The radiologic evidance in distinguishing the pleural mesothelioma from the pleural metastatic adenocarcinoma
Source: Eur Respir J 2006; 28: Suppl. 50, 93s
Year: 2006
Cytology of pleural fluid versus histopathology of the pleura in the diagnosis of malignant pleural effusions
Source: Eur Respir J 2006; 28: Suppl. 50, 775s
Year: 2006
Effect of sampling phase of pleural fluid on the abundance of malignant cells in cytologic smears of effusions due to adenocarcinoma
Source: Annual Congress 2009 - Diagnosis and management of pleural effusions and mesothelioma: improving old techniques and new tools
Year: 2009
Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010
An update on treatment of malignant pleural effusion with or without known primary bronchial adenocarcinoma
Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis
Year: 2006
Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma
Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions
Year: 2012
Malignant pleural effusion cells show aberrant glucose metabolism gene expression
Source: Eur Respir J 2011; 37: 1453-1465
Year: 2011
Use of carcinoembryonic antigen in pleural effusion for differential diagnosis of benign and malignant pleural effusion
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008
Quick immunohistochemical diagnosis of neoplasia pleural effusions
Source: Eur Respir J 2006; 28: Suppl. 50, 581s
Year: 2006
Pathological diagnosis of malignant pleural mesothelioma
Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Year: 2020
Biochemical and cytological features of metastatic pleural effusions in breast cancer
Source: Eur Respir J 2007; 30: Suppl. 51, 671s
Year: 2007
Cytology and DNA ploidy techniques in the diagnosis of malignant pleural effusion
Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions
Year: 2012
Evaluation of pleural fluid human epididymis 4 (HE4) as a marker of malignant pleural effusions
Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions
Year: 2012
Closed pleural needle biopsy and pleural fluid examination in pathological diagnosis of malignant pleural effusion
Source: Eur Respir J 2003; 22: Suppl. 45, 256s
Year: 2003
Expression of human mammaglobin gene in pleural effusion of patients affected by malignant pleural mesothelioma (MM)
Source: Eur Respir J 2004; 24: Suppl. 48, 81s
Year: 2004
Closed pleural brushing in the diagnosis of malignant pleural effusions
Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases
Year: 2008
The Abrams pleural biopsy is still useful in the diagnosis of pleural effusions
Source: Annual Congress 2009 - Pleural diseases
Year: 2009
Utility of pleural fluid for predictive marker testing in malignant pleural effusion
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020
Usefulness of cytology and blind needle pleural biopsy (BNPB) histopathology findings in malignant pleural effusions
Source: Eur Respir J 2006; 28: Suppl. 50, 50s
Year: 2006
Diagnostic value of detection of promoter hypermethylation of tumor suppressor genes in pleural fluid for diagnosis of malignant pleural effusion
Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept